Absorption of paroxetine under various dietary conditions and following antacid intake.
Greb
W H
WH
Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of Germany.
Brett
M A
MA
Buscher
G
G
Dierdorf
H D
HD
von Schrader
H W
HW
Wolf
D
D
Mellows
G
G
Zussman
B D
BD
D000284:Administration, Oral; D000328:Adult; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D000818:Animals; D000928:Antidepressive Agents / Q000493:pharmacokinetics*; D002986:Clinical Trials as Topic; D004041:Dietary Fats / Q000008:administration & dosage; D005247:Feeding Behavior; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D008892:Milk; D017374:Paroxetine; D010880:Piperidines / Q000493:pharmacokinetics*; D012702:Serotonin Antagonists / Q000493:pharmacokinetics*
D000928:Antidepressive Agents; D004041:Dietary Fats; D010880:Piperidines; D012702:Serotonin Antagonists; D017374:Paroxetine; D000536:Aluminum Hydroxide